Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9819921 | 1.00 | SHBG (0.44) | SHBGEPHX1CYP2C9CYP2C19HIF1A | |
| SCHEMBL9819799 | 0.97 | — | — | |
| SCHEMBL9819847 | 0.92 | — | — | |
| SCHEMBL140295 | 0.86 | — | — | |
| SCHEMBL6303768 | 0.80 | SHBG (0.41) | SHBGEPHX1TP53CA12CA1 | |
| SCHEMBL19003119 | 0.79 | SHBG (0.44) | SHBGEPHX1TP53CA12CA1 | |
| SCHEMBL748900 | 0.78 | SHBG (0.48) | SHBGEPHX1TP53CA12CA1 | |
| SCHEMBL1192741 | 0.76 | SHBG (0.59) | SHBGEPHX1CYP2C9CYP2C19TP53 | |
| SCHEMBL30491952 | 0.76 | SHBG (0.59) | SHBGEPHX1CYP2C9CYP2C19TP53 | |
| SCHEMBL486924 | 0.76 | SHBG (0.59) | SHBGEPHX1CYP2C9CYP2C19TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1531395-B | Method of improving yield and vigor of plants | MONSANTO TECHNOLOGY LLC | 2012-06-13 | — | — | CN | disclosed |
| CN-100415750-C | Fungicides for the control of take-all disease of plants | MONSANTO CO (US) | 2008-09-03 | — | — | CN | disclosed |
| CN-101099460-A | Method of microencapsulating an agricultural active having a high melting point and uses for such materials | MONSANTO TECHNOLOGY LLC (US) | 2008-01-09 | — | — | CN | disclosed |
| CN-100337541-C | Method for microencapsulating agrochemical active substances having a high melting point and use of these substances | MONSANTO TECHNOLOGY LLC (US) | 2007-09-19 | — | — | CN | disclosed |
| CN-1772749-A | Fungicides for the control of take-all disease of plants | MONSANTO CO (US) | 2006-05-17 | — | — | CN | disclosed |
| CN-1239495-C | Bactericide for preventing and treating plant take-all disease | MONSANTO CO (US) | 2006-02-01 | — | — | CN | disclosed |
| US-20050171185-A1 | Indole derivatives | FUJISAWA PHARMACEUTICAL CO., LTD., A JAPANESE CORPORATION | 2005-08-04 | — | — | US | disclosed |
| CN-1636457-A | Fungicides for the control of take-all disease of plants | MONSANTO CO (US) | 2005-07-13 | — | — | CN | disclosed |
| US-6869950-B1 | Benzimidazole derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-03-22 | — | — | US | disclosed |
| CN-1188419-C | Bactericide for preventing and treating plant take-all disease | MONSANTO CO (US) | 2005-02-09 | — | — | CN | disclosed |
| CN-1221745-A | Bactericide for preventing and treating plant take-all disease | MONSANTO CO (US) | 1999-07-07 | — | — | CN | disclosed |
| CN-1221746-A | Bactericide for preventing and treating plant take-all disease | MONSANTO CO (US) | 1999-07-07 | — | — | CN | disclosed |
| CN-1043835-C | Bactericide for preventing and treating plant take-all disease | MONSANTO CO (US) | 1999-06-30 | — | — | CN | disclosed |
| US-5719257-A | OBTAINED BY ANIONIC POLYMERIZATION OF DERIVATIVES OF 2,2,6,6-TETRAMETHYL-4-/2,3-EPOXYPROPOXY/PIPERIDINE | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-02-17 | — | — | US | disclosed |
| US-5616637-A | PHOTOSTABILITY; OXIDTION AND HEAT RESISTANT | CIBA-GEIGY CORPORATION (US) | 1997-04-01 | — | — | US | disclosed |
| US-5521282-A | FROM 4-/2,3-EPOXYPROPOXY/-2,2,6,6-TETRAMETHYLPIPERIDINE | CIBA-GEIGY CORPORATION (US) | 1996-05-28 | — | — | US | disclosed |
| EP-0634449-A2 | Polyether with sterically hindered amine side chains as stabilizing agents | CIBA-GEIGY AG (CH) | 1995-01-18 | — | — | EP | disclosed |
| CN-1085221-A | Bactericide for preventing and treating plant take-all disease | MONSANTO CO (US) | 1994-04-13 | — | — | CN | disclosed |
| US-4987132-A | PLATELET ACTIVATING FACTOR ANTAGONISTS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1991-01-22 | — | — | US | disclosed |
| EP-0279681-A2 | Saturated heterocyclic carboxamide derivatives | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1988-08-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050171185-A1 | Indole derivatives | PDE5A, IGFBP5, HTR5A | SHBG 656/4885EPHX1 3698/4885CYP2C9 1541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.